OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 34 citing articles:

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
César U. Monjarás-Ávila, Ana C. Lorenzo‐Leal, Ana C. Luque-Badillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7946-7946
Open Access | Times Cited: 48

Emerging biomaterials for tumor immunotherapy
Minna Xiao, Qinglai Tang, Shiying Zeng, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 43

Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 27

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy
He Jiang, You Zhou, Lun‐Quan Sun
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12

Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics
Chong Zhao, Benqing Zhou
Journal of Functional Biomaterials (2022) Vol. 14, Iss. 1, pp. 12-12
Open Access | Times Cited: 29

New advances into cisplatin resistance in head and neck squamous carcinoma: Mechanisms and therapeutic aspects
Hanlin Hu, Bo Li, Junke Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114778-114778
Open Access | Times Cited: 17

Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment
Si Sun, Qiang Yang, Dawei Jiang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

Surface-functionalised polymeric nanoparticles for breast cancer treatment: processes and advances
Aprameya Ganesh Prasad, Mohamed Mofreh Bakr, Aliaa Nabil ElMeshad
Journal of drug targeting (2024) Vol. 32, Iss. 7, pp. 770-784
Closed Access | Times Cited: 6

Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37376-e37376
Open Access | Times Cited: 4

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities
Jiarui Zhang, Jin‐an Zhang, Yang Chen
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

In vitro analysis of the molecular mechanisms of ursolic acid against ovarian cancer
Ru Zhang, Zhaopeng Zhang, Lulu Xie, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access

Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy
Sohaib Mahri, Raffaella Villa, Ya‐Ping Shiau, et al.
Small Science (2025)
Open Access

Unveiling autophagy complexity in leukemia: The molecular landscape and possible interactions with apoptosis and ferroptosis
Young Yun Jung, Kwang Seok Ahn, Mingzhi Shen
Cancer Letters (2023) Vol. 582, pp. 216518-216518
Closed Access | Times Cited: 8

Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms
Gang Zhao, Yutao Wang, Zhongru Fan, et al.
Cancer Letters (2024) Vol. 591, pp. 216860-216860
Closed Access | Times Cited: 3

Plasmacytoid Dendritic Cells Mediate CpG-ODN Induced Increase in Survival in a Mouse Model of Lymphangioleiomyomatosis
Mayowa Amosu, Ashleigh M. Jankowski, Jacob McCright, et al.
American Journal of Respiratory Cell and Molecular Biology (2024) Vol. 71, Iss. 5, pp. 519-533
Closed Access | Times Cited: 3

Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
Hang Dong, Meng Gao, Lu Lu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3577-3593
Open Access | Times Cited: 7

Autophagy/ferroptosis in colorectal cancer: Carcinogenic view and nanoparticle-mediated cell death regulation
Zhibin Zhang, Yintao Zhao, Yuman Wang, et al.
Environmental Research (2023) Vol. 238, pp. 117006-117006
Closed Access | Times Cited: 7

Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
Jenny Schunke, Volker Mailänder, Katharina Landfester, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12174-12174
Open Access | Times Cited: 4

A fatty acid-rich fraction of an endolichenic fungus Phoma sp. suppresses immune checkpoint markers via AhR/ARNT and ESR1
Mücahit Varlı, Men Thi Ngo, Seongmin Kim, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19185-e19185
Open Access | Times Cited: 4

Microneedle pretreatment and cationic nanoparticles for transdermal delivery of doxorubicin against melanoma
Xiaopeng Yang, Le Chang, Qian Lin, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105417-105417
Closed Access | Times Cited: 1

Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer
Caroline B. Linde, Yu-Ting Chien, Zhiqian Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1

Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds
Canhui Jin, Tianbao Wang, Yanhui Yang, et al.
Environmental Research (2023) Vol. 227, pp. 115721-115721
Closed Access | Times Cited: 3

Investigation and verification of GIMAP6 as a robust biomarker for prognosis and tumor immunity in lung adenocarcinoma
Xiuqiong Chen, Zhaona Li, Xinyue Wang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11041-11055
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top